Addressing Patient Concerns About Biosimilars: Reducing Hesitation and Building Trust
23
Feb
Medications
Peyton Holyfield
Biosimilars offer major cost savings and proven safety, yet patient hesitation remains high. Learn why they’re not generics, how they’re tested, and what really causes fear-and how to overcome it.
ReadMore